Opitma Medical Innovations Corp. (Formerly Tree of Knowledge International Corp.) Provides Update on Name Change and Share Consolidation
Back to Newsroom
Mentioned in this Article

Opitma Medical Innovations Corp. (Formerly Tree of Knowledge International Corp.) Provides Update on Name Change and Share Consolidation

Thursday, November 18, 2021 9:45 AM
Share this article now
Company Name Change
Optima Medical Innovations Corp.

TORONTO, ON / ACCESSWIRE / November 18, 2021 / Optima Medical Innovations Corp. ("OMIC" or the "Company") as previously disclosed in the Company's October 1, 2021 press release and approved by the shareholders of the Company, is pleased to announce the official name change of the company from Tree of Knowledge International Corp. to Optima Medical Innovations Corp. (the "Name Change") and the finalization of the share consolidation on a five (5) for one (1) basis (the "Consolidation").

The common shares of the Company are to begin trading on a post-consolidation basis at market open on November 18, 2021 under the stock symbol "OMIC". The new CUSIP number will be 68405M109 and ISIN CA68405M1095. Following the Name Change and Consolidation, the Company will have 47,500,130 common shares issued and outstanding.

The Canadian Securities Exchange has approved the Name Change and Share Consolidation and issued a Bulletin on November 17, 2021 advising of the Consolidation and Name Change. No action is required by shareholders to effect the Consolidation and Name Change. No fractional common shares have been issued upon the Consolidation.

The Company confirms that except as disclosed previously in its news releases, there have been no material changes to the Company or its business.

For further information on the Company

Please Visit: Company's Website
Contact: CEO - Ommid Faghani

About Optima Medical Innovations Corp.

Optima Medical Innovations Corp. is a public company that delivers pathways to innovative, science-based health and wellness solutions.

OMIC sees the future of medicine in novel individualized and targeted treatments.

The Company is a leader in multi-disciplinary pain management with focus on wellness. Our goal is to empower patients in their journey to wellness through education and best medical practices and innovations. Built upon an extensive network of scientific and medical research, OMIC is an advanced leader in the development of focused solutions, products and treatments for pain relief, wellness and Cancer therapy. Optima Medical Innovations Corp. spans the globe with its multidisciplinary pain clinics, research partners, education and advocacy programs - all working in harmony to bring health and wellness to the world, while creating value for shareholders and partners.

Forward Looking Statements

Except for statements of historical fact relating to the Company, certain information contained herein constitutes forward-looking statements. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. Except as required by applicable securities laws, the Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change. The reader is cautioned not to place undue reliance on forward-looking statements.


SOURCE: Optima Medical Innovations Corp.

Back to Newsroom
Copyright 2022 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions